Skip to content
Wenlo
Sign in
← Markets

NeuroPace, Inc.

Martha Morrell (CHIEF MEDICAL OFFICER) reports NPCE insider transactions

4NPCEFiled Sep 25, 2026, 12:31 PM ET· Period Sep 24, 2026

About this filing

NeuroPace, Inc. (NPCE) filed Form 4 (insider transaction) with the SEC on Sep 25, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Martha Morrell · CHIEF MEDICAL OFFICER
DateTransactionSharesPriceValueHeld afterOwnership
Sep 24, 2026F · tax withholdingFootnotes F1−335$13.97$4,679.9551,357Direct
Footnotes
  1. F1 Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

More NPCE filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.